3-iodobenzylguanidine has been researched along with Depression in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bono, K; Iguchi, Y; Komatsu, T; Maku, T; Mitsumura, H; Motegi, H; Murakami, H; Nakada, R; Omoto, S; Sakai, K; Sato, T; Shiraishi, T; Takahashi, M; Takatsu, H; Umehara, T | 1 |
| Eriguchi, M; Fujioka, S; Hara, H; Hattori, N; Houzen, H; Li, Y; Mishima, T; Nishioka, K; Sato, K; Shiomi, K; Tsuboi, Y; Yabe, I | 1 |
| Esumi, S; Hayashi, S; Hinotsu, K; Oshima, E; Shinya, T; Takenoshita, S; Terada, S; Yamada, N; Yamaguchi, M | 1 |
| Berg, D; Postuma, RB | 1 |
| Bokhari, S; Burg, M; Davidson, KW; Onyeji, I; Peacock, J; Whang, W | 1 |
1 review(s) available for 3-iodobenzylguanidine and Depression
| Article | Year |
|---|---|
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
4 other study(ies) available for 3-iodobenzylguanidine and Depression
| Article | Year |
|---|---|
Differences in correlations of depression and anhedonia with cardiovascular sympathetic functions during a head-up tilt test in drug-naïve Parkinson's disease patients.
Topics: 3-Iodobenzylguanidine; Anhedonia; Depression; Humans; Parkinson Disease; Pharmaceutical Preparations | 2020 |
Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Biomarkers; Depression; Dynactin Complex; Female; Humans; Hypoventilation; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Pedigree; Radiopharmaceuticals | 2021 |
Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Depression; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radionuclide Imaging; Radiopharmaceuticals | 2019 |
Antidepressant use is associated with reduced myocardial mIBG uptake in CAD patients.
Topics: 3-Iodobenzylguanidine; Aged; Antidepressive Agents; Coronary Artery Disease; Depression; Female; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |